Search Videos and More

Showing 1 - 12 of 79 results

Previous| 1 | 2 | 3 ...7 |Next


Miami Brain Symposium, Seventh Annual News

Miami Brain Symposium, Seventh Annual

The Miami Brain Symposium will focus on state-of-the-art approaches to the management of primary and metastatic central nervous systems tumors, along with an understanding of current standards of care and a look at future directions.
SRS With Immunotherapy Extends Survival in RCC With Brain Metastasis News

SRS With Immunotherapy Extends Survival in RCC With Brain Metastasis

According to Manmeet Ahluwalia, MD, MBA, FASCO, kidney cancer currently ranks as the fourth most common cancer to metastasize to the brain after lung cancer, breast cancer, and melanoma.
Minesh P. Mehta, MD, on NSCLC: Tumor Treating Fields for Brain Metastases News

Minesh P. Mehta, MD, on NSCLC: Tumor Treating Fields for Brain Metastases

Minesh P. Mehta, MD, of Miami Cancer Institute, part of Baptist Health South Florida, discusses results from the METIS (EF-25) trial evaluating the efficacy and safety of tumor treating fields therapy following stereotactic radiosurgery in patients with mutation-negative non–small cell lung cancer (NSCLC) and brain metastases.
Miami Cancer Institute Leads First-in-World Brain Metastasis Trial News

Miami Cancer Institute Leads First-in-World Brain Metastasis Trial

Baptist Health Miami Cancer Institute is leading a groundbreaking clinical trial that is studying the use of a new medication combined with stereotactic radiosurgery to combat metastatic brain cancer.
Miami Cancer Institute Publication Analyzes Role of Tissue-Agnostic Therapies for the Treatment of Primary Brain Tumors News

Miami Cancer Institute Publication Analyzes Role of Tissue-Agnostic Therapies for the Treatment of Primary Brain Tumors

Researchers from Miami Cancer Institute, part of Baptist Health South Florida, recently published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs). The publication describes the current and potential impact of tissue-agnostic therapies on the management of PBTs. As part of the publication, the researchers discuss data from clinical trials of tissue-agnostic targets for PBTs in the context of challenges in managing these tumors. They also describe additional tissue-agnostic targets that hold promise for benefiting patients with PBTs.
Advanced Prostate Cancer: Genetic Testing an Invaluable Tool News

Advanced Prostate Cancer: Genetic Testing an Invaluable Tool

A study led by Baptist Health Miami Cancer Institute shows that patients with TP53, RB1 and PTEN mutated prostate cancer have a lower overall survival rate than patients who are biomarker negative. The results emphasize the importance of genetic testing for all advanced cancer patients, the researchers say.
Miami Cancer Institute to Host Fifth Global Summit on Immunotherapies for Hematologic Malignancies News

Miami Cancer Institute to Host Fifth Global Summit on Immunotherapies for Hematologic Malignancies

Miami Cancer Institute, part of Baptist Health South Florida, announced it will host the Fifth Annual Global Summit on Immunotherapies for Hematologic Malignancies, to be held March 8-9, 2024, at the JW Marriott Hotel in Brickell, Miami, Fla.
Miami Cancer Institute Achieves AAHRPP Accreditation News

Miami Cancer Institute Achieves AAHRPP Accreditation

The Association for Accreditation of Human Research Protection Programs has recognized Miami Cancer Institute for promoting ethically sound and safe human subject research practices.
Novel Artificial Intelligence Technology Shows Promising Results for Earlier and More Accurate Breast Cancer Detection News

Novel Artificial Intelligence Technology Shows Promising Results for Earlier and More Accurate Breast Cancer Detection

Data from the Centers for Disease Control and Prevention highlight that Breast Cancer is second most common form of cancer among women in the U.S. with approximately 240,000 new breast cancer diagnoses each year.
Meet the Chief: Music, Sports and Yoga Keep Surgeon Horacio Asbun, M.D., Focused News

Meet the Chief: Music, Sports and Yoga Keep Surgeon Horacio Asbun, M.D., Focused

During his more than 25 years in the field, and as chief of Hepatobiliary and Pancreas Surgery at Baptist Health Miami Cancer Institute since 2018, Horacio Asbun, M.D., has been at the very forefront of global pancreatic cancer research and treatment.
Why are More Young Women Being Diagnosed with Lung Cancer Than Young Men? News

Why are More Young Women Being Diagnosed with Lung Cancer Than Young Men?

In a reversal of historic trends, researchers at the American Cancer Society (ACS) have found higher lung cancer incidence in women than in men between the ages of 35 and 54.
Paving the Way to New Treatment for Non-Small Cell Lung Cancer that Has Spread to the Brain News

Paving the Way to New Treatment for Non-Small Cell Lung Cancer that Has Spread to the Brain

Multi-institutional study found that V12 Gy given to radiosurgical volume of larger than 10 cm3 , was a significant predictor of radiation necrosis in patients with brain metastasis from non-small cell lung cancer

Showing 1 - 12 of 79 results

Previous| 1 | 2 | 3 ...7 |Next